Loading...
Loading...
Among the 7 tracked institutional investors we monitor, INO (INOVIO PHARMACEUTICALS INC) is held with a combined value of $28.00M across 16,090,159 shares. The largest holder is FMR LLC with a position worth $16.25M (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 4 funds increased their holdings. 2 funds reduced their position.
Total Institutional Value
$28.00M
Total Shares Held
16,090,159
Institutional Holders
7
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | FMR LLC | $16.25M | 0.00% | -5.1% |
| 2 | VANGUARD GROUP INC | $5.77M | 0.00% | New |
| 3 | MILLENNIUM MANAGEMENT LLC | $2.45M | 0.00% | +0.5% |
| 4 | BlackRock, Inc. | $1.15M | 0.00% | +7.2% |
| 5 | RENAISSANCE TECHNOLOGIES LLC | $1.12M | 0.00% | +16.4% |
| 6 | CITADEL ADVISORS LLC | $734.02K | 0.00% | -1.7% |
| 7 | STATE STREET CORP | $515.58K | 0.00% | +19.8% |
As of the latest SEC 13F filings, FMR LLC is the largest institutional holder of INO with a position worth $16.25M, representing 0.00% of their portfolio. In total, 7 institutional investors hold INO with a combined value of $28.00M.
In the most recent quarter, 1 fund opened a new position in INO. Additionally, 4 increased their holdings and 2 reduced their positions.
Institutional investors hold $28.00M worth of INO stock across 7 positions. The largest institutional holder is FMR LLC with $16.25M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For INO, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their INO positions.